
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Stocks | 67.46 | 67.46 | 0.00 |
Bonds | 32.54 | 32.54 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 24.59 | 16.33 |
Price to Book | 5.18 | 2.42 |
Price to Sales | 3.36 | 1.80 |
Price to Cash Flow | 18.75 | 10.58 |
Dividend Yield | 1.08 | 2.54 |
5 Years Earnings Growth | 9.49 | 10.22 |
Name | Net % | Category Average |
---|---|---|
Technology | 34.51 | 18.24 |
Healthcare | 21.24 | 10.73 |
Financial Services | 16.62 | 17.98 |
Consumer Cyclical | 10.44 | 10.39 |
Consumer Defensive | 6.52 | 7.09 |
Industrials | 6.15 | 13.33 |
Basic Materials | 2.29 | 4.93 |
Communication Services | 2.23 | 7.24 |
Number of long holdings: 49
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Mastercard | US57636Q1040 | 4.27 | 479.92 | -1.15% | |
Fiserv | US3377381088 | 3.71 | 195.59 | -1.44% | |
London Stock Exchange | GB00B0SWJX34 | 3.53 | 10,743.3 | -1.21% | |
Marsh McLennan | US5717481023 | 3.41 | 220.65 | -1.38% | |
Labcorp Holdings | US5049221055 | 3.05 | 217.68 | -2.60% | |
Thermo Fisher Scientific | US8835561023 | 3.04 | 419.31 | -4.24% | |
Accenture | IE00B4BNMY34 | 2.90 | 281.39 | -1.17% | |
Experian | GB00B19NLV48 | 2.80 | 3,182.0 | -2.93% | |
Microsoft | US5949181045 | 2.77 | 354.56 | -0.92% | |
United Kingdom of Great Britain and Northern Ireland 0.125% | GB00BNNGP551 | 2.71 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
The New Floco Inc | 129.42M | 3.33 | 6.26 | 8.14 | ||
OHP Fund | 15.7M | 3.15 | 11.68 | 9.21 | ||
The New Jaguar Inc | 9.84M | 3.17 | 11.98 | 9.72 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review